MDGL R&D Expense Growth
Madrigal Pharmaceuticals Inc · R&D Expense Growth
MDGL R&D Expense Growth
Latest reported64.13%period ending
MDGL FY R&D Growth (YoY) (0.00% → 64.13%)
Latest values, visible window
High-resolution chart · PNG
MDGL r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 64.1299% | |
| -13.0832% | |
| 10.9635% | |
| 19.6316% | |
| 11.0141% | |
| 155.5293% | |
| 184.8635% | |
| 4.0959% | |
| 53.0689% | |
| -70.6112% | |
| -20.5073% | |
| -5.0863% | |
| 45.4303% | |
| 19.1684% | |
| 3.011% | |
| -21.158% | |
| -37.4193% | |
| 56.8111% | |
| 3.0137% | |
| -15.6892% | |
| 57.0721% | |
| 56.6997% | |
| 233.7493% | |
| 2,532.491% | |
| 0% |